Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic …

F Barlesi, J Mazieres, JP Merlio, D Debieuvre, J Mosser… - The Lancet, 2016 - thelancet.com
Background The molecular profiling of patients with advanced non-small-cell lung cancer
(NSCLC) for known oncogenic drivers is recommended during routine care. Nationally …
被引用次数：963 相关文章

Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic …

F Barlesi, J Mazieres, JP Merlio, D Debieuvre, J Mosser… - The Lancet, 2016 - infona.pl
The molecular profiling of patients with advanced non-small-cell lung cancer (NSCLC) for
known oncogenic drivers is recommended during routine care. Nationally, however, the …
[PDF] ifct.fr

[PDF][PDF] Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic …

F Barlesi, J Mazieres, JP Merlio, D Debieuvre, J Mosser… - 2016 - ifct.fr
Background The molecular profiling of patients with advanced non-small-cell lung cancer
(NSCLC) for known oncogenic drivers is recommended during routine care. Nationally …

Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic …

F Barlesi, J Mazieres, JP Merlio… - Lancet (London …, 2016 - europepmc.org
Background The molecular profiling of patients with advanced non-small-cell lung cancer
(NSCLC) for known oncogenic drivers is recommended during routine care. Nationally …

Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic …

F Barlesi, J Mazieres, JP Merlio, D Debieuvre, J Mosser… - The Lancet, 2016 - Elsevier
Background The molecular profiling of patients with advanced non-small-cell lung cancer
(NSCLC) for known oncogenic drivers is recommended during routine care. Nationally …

Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic …

F Barlesi, J Mazieres, JP Merlio… - Lancet (London …, 2016 - pubmed.ncbi.nlm.nih.gov
Background The molecular profiling of patients with advanced non-small-cell lung cancer
(NSCLC) for known oncogenic drivers is recommended during routine care. Nationally …

Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic …

F Barlesi, J Mazieres, JP Merlio, D Debieuvre, J Mosser… - The Lancet, 2016 - thelancet.com
Background The molecular profiling of patients with advanced non-small-cell lung cancer
(NSCLC) for known oncogenic drivers is recommended during routine care. Nationally …

[引用][C] Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic …

F Barlesi, J Mazieres, JP Merlio, D Debieuvre, J Mosser… - The Lancet, 2016 - cir.nii.ac.jp
Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a
1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT) | CiNii …

[引用][C] Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic …

F Barlesi, J Mazieres, JP Merlio, D Debieuvre… - The …, 2016 - Elsevier Limited